Top

European Spine Journal

Published in:

01-02-2013 | Chinese section

Short-term alendronate treatment does not maintain a residual effect on spinal fusion with interbody devices and bone graft after treatment withdrawal: an experimental study on spinal fusion in pigs

Authors: Baoding Huang, Xuenong Zou, Haisheng Li, Qingyun Xue, Cody Bünger

Published in: European Spine Journal | Issue 2/2013

Abstract

Purpose

Whether alendronate treatment has a residual effect on bone ingrowth into porous biomaterial in humans or experimental animals after treatment withdrawal is still unknown. The purpose of this study was to investigate bone ingrowth into porous tantalum and carbon fiber interbody implants after discontinuing alendronate treatment in experimental spinal fusion in pigs.

Methods

Twenty-four pigs were randomly divided into two groups of each 12 pigs. The pigs underwent anterior intervertebral lumbar arthrodeses at L2–3, L4–5 and L6–7. Each level was randomly allocated to one of the three implants: a porous tantalum ring with pedicle screw fixation, a porous tantalum ring or a carbon fiber cage with anterior staple fixation. The central hole of implants was packed with an autograft. Alendronate was given orally for the first 3 months to one of the two groups. The pigs were observed for 6 months postoperatively. Histology and micro-CT scans were done at the endpoint.

Results

The spinal fusion rates of each implant showed no differences between two treatment groups. Furthermore, no differences were found between two groups as for bone ingrowth into the central holes of implants and bone–implant interface in each implant, or as for the pores of tantalum implants. Trabecular bone microarchitecture in the central hole of the carbon fiber cage did not differ between two treatment groups.

Conclusion

The application of ALN, with a dose equivalent to that given to humans during the first 3 months after surgery, does not maintain a residual effect on spinal fusion with porous tantalum ring and autograft after treatment withdrawal in a porcine ALIF model.

Liberman UA, Weiss SR, Broll J et al (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate phase III osteoporosis treatment study group. N Engl J Med 333:1437–1443PubMedCrossRef

Zou X, Xue Q, Li H et al (2003) Effect of alendronate on bone ingrowth into porous tantalum and carbon fiber interbody devices: an experimental study on spinal fusion in pigs. Acta Orthop Scand 74:596–603PubMedCrossRef

Nakao SI, Minamide A, Kawakami M et al (2011) The influence of alendronate on spine fusion in an osteoporotic animal model. Spine (Phila Pa 1976) 36:1446–1452CrossRef

Huang RC, Khan SN, Sandhu HS et al (2005) Alendronate inhibits spine fusion in a rat model. Spine (Phila Pa 1976) 30:2516–2522CrossRef

Lehman RA Jr, Kuklo TR, Freedman BA et al (2004) The effect of alendronate sodium on spinal fusion: a rabbit model. Spine J 4:36–43PubMedCrossRef

Sama AA, Khan SN, Myers ER et al (2004) High-dose alendronate uncouples osteoclast and osteoblast function: a study in a rat spine pseudarthrosis model. Clin Orthop Relat Res 425:135–142PubMedCrossRef

Peter CP, Cook WO, Nunamaker DM et al (1996) Effect of alendronate on fracture healing and bone remodeling in dogs. J Orthop Res 14:74–79PubMedCrossRef

Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358:1304–1306PubMedCrossRef

Lin JH, Russell G, Gertz B (1999) Pharmacokinetics of alendronate: an overview. Int J Clin Pract Suppl 101:18–26PubMed

10.

Bagger YZ, Tanko LB, Alexandersen P et al (2003) Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal. Bone 33:301–307PubMedCrossRef

11.

Bobyn JD, Stackpool GJ, Hacking SA et al (1999) Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. J Bone Joint Surg Br 81:907–914PubMedCrossRef

12.

Bobyn JD, Toh KK, Hacking SA et al (1999) Tissue response to porous tantalum acetabular cups: a canine model. J Arthroplasty 14:347–354PubMedCrossRef

13.

Zou X, Li H, Bünger M et al (2004) Bone ingrowth characteristics of porous tantalum and carbon fiber interbody devices: an experimental study in pigs. Spine J 4:99–105PubMedCrossRef

14.

Bünger MH, Foss M, Erlacher K et al (2006) Bone nanostructure near titanium and porous tantalum implants studied by scanning small angle X-ray scattering. Eur Cell Mater 12:81–91PubMed

15.

Xue Q, Li H, Zou X et al (2010) Alendronate treatment improves bone-pedicle screw interface fixation in posterior lateral spine fusion: an experimental study in a porcine model. Int Orthop 34:447–451PubMedCrossRef

16.

Ding M, Odgaard A, Hvid I (1999) Accuracy of cancellous bone volume fraction measured by micro-CT scanning. J Biomech 32:323–326PubMedCrossRef

17.

Nagahama K, Kanayama M, Togawa D et al (2011) Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial. J Neurosurg Spine 14:500–507PubMedCrossRef

18.

Duarte PM, de Vasconcelos Gurgel BC, Sallum AW et al (2005) Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats. J Periodontol 76:107–114PubMedCrossRef

19.

Nishitani K, Shirai T, Kobayashi M et al (2009) Positive effect of alendronate on subchondral bone healing and subsequent cartilage repair in a rabbit osteochondral defect model. Am J Sports Med 37:139S–147SPubMedCrossRef

20.

Lund T, Oxland TR, Jost B et al (1998) Interbody cage stabilisation in the lumbar spine: biomechanical evaluation of cage design, posterior instrumentation and bone density. J Bone Joint Surg Br 80:351–359PubMedCrossRef

21.

Sagomonyants KB, Hakim-Zargar M, Jhaveri A et al (2011) Porous tantalum stimulates the proliferation and osteogenesis of osteoblasts from elderly female patients. J Orthop Res 29(4):609–616PubMedCrossRef

22.

Schenk RK, Felix R, Hofstetter W (1993) Morphology of connective tissue: bone. In Royce, PM, Steinmann B (eds) Connective Tissue and Its Heritable Disorders. Molecular, genetic, and medical aspects, Wiley-Liss, New York, pp 85–101

Title: Short-term alendronate treatment does not maintain a residual effect on spinal fusion with interbody devices and bone graft after treatment withdrawal: an experimental study on spinal fusion in pigs
Authors: Baoding Huang
Xuenong Zou
Haisheng Li
Qingyun Xue
Cody Bünger
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: European Spine Journal / Issue 2/2013
Print ISSN: 0940-6719
Electronic ISSN: 1432-0932
DOI: https://doi.org/10.1007/s00586-012-2513-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Short-term alendronate treatment does not maintain a residual effect on spinal fusion with interbody devices and bone graft after treatment withdrawal: an experimental study on spinal fusion in pigs

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2013

How is the trachea at risk of injury from pedicle screw insertion in proximal thoracic curve of adolescent idiopathic scoliosis patients?

C1–2 transarticular screws combined with C1 laminar hooks fixation: a modified posterior atlantoaxial fixation technique and outcome in 72 patients

Posterior correction of thoracic adolescent idiopathic scoliosis with pedicle screw instrumentation: results of 48 patients with minimal 10-year follow-up

A systematic review of the clinical effectiveness of EOS 2D/3D X-ray imaging system

The Michel Benoist and Robert Mulholland yearly European Spine Journal Review

Announcements for issue 22-2-2013